ELEVO

An investment platform for deep-tech innovations, backing scientific research and helping it leave the lab. Behind it are executives from Intel, Generative Bionics, ArmaVir Partners, and Johnson & Johnson MedTech.

ELEVO

Thousands of technologies come out of labs every year. Less than 10% reach the market. We back ELEVO because a discovery that stays locked in a lab has no impact on people’s lives.ELEVO is a technology transfer platform that works with research centers to identify, accelerate and scale scientific discoveries: robotics, AI, biotech, advanced materials, health, energy. The model is to co-found the companies, with a proprietary assessment system that screens opportunities on technical maturity and market relevance.It was co-founded by H-FARM together with Maurizio Martinoli, Davide Rota and Andrea Pagnin, the latter two already co-founders of Generative Bionics, the Italian Institute of Technology spin-off in humanoid robotics that closed a €70 million round in December 2025. Executives from Intel, ArmaVir Partners and Johnson & Johnson MedTech have also invested.More info